Peptide V3 Inhibits the Growth of Human Hepatocellular Carcinoma by Inhibiting the Ras/Raf/MEK/ERK Signaling Pathway

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths. Peptide V3 has shown anti-angiogenic and anti-tumor effects on S180 and H22 xenografts in nude mice. However, the detailed mechanism of action of peptide V3 has not yet been fully elucidated. In the present study,...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Dongdong, Li, Mengling, Gao, Yingran, Tian, Wenke, Li, Jianmei, Zhang, Qianqian, Liu, Zhengguo, Zheng, Mengli, Wang, Hongju, Wang, Jun, Teng, Tieshan, Zhang, Lei, Ji, Xinying, Xie, Zhongwen, Ji, Ailing, Li, Yanzhang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6548006/
https://www.ncbi.nlm.nih.gov/pubmed/31205525
http://dx.doi.org/10.7150/jca.29211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6548006/
https://www.ncbi.nlm.nih.gov/pubmed/31205525
http://dx.doi.org/10.7150/jca.29211

Ejemplares similares